Introduction Semaglutide has emerged as a revolutionary medication in the realm of healthcare, targeting conditions like obesity, type 2 diabetes, and cardiovascular risks. Part of the GLP-1 receptor agonists family, Semaglutide mimics the hormone glucagon-like peptide-1 (GLP-1), which plays a pivotal role in regulating blood sugar, stimulating insulin release, and https://felixycehj.wikihearsay.com/3051235/semaglutide_a_revolutionary_treatment_for_diabetes_obesity_and_heart_health